NCT03091621View on ClinicalTrials.gov

Japanese Registry of Rivaroxaban Effectiveness & Safety for the Prevention of Recurrence in Patients With Deep Vein Thrombosis and Pulmonary Embolism

UnknownOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions
Deep Vein ThrombosisPulmonary Embolism
Trial Locations (1)

1738610

RECRUITING

Nihon University School of Medicine, Tokyo

Sponsors

Collaborators (1)

Mebix Inc
All Listed Sponsors
collaborator

Mebix Inc

INDUSTRY

lead

Nihon University

OTHER

NCT03091621 - Japanese Registry of Rivaroxaban Effectiveness & Safety for the Prevention of Recurrence in Patients With Deep Vein Thrombosis and Pulmonary Embolism | Biotech Hunter | Biotech Hunter